According to THE SAGE GROUP, Peripheral Artery Disease (PAD) Afflicts 28 Million Western Europeans and 4.2 Million Suffer From Critical Limb Ischemia (CLI)
BEAUFORT SC, May 19, 2017 (BUSINESS WIRE)—An analysis published by THE SAGE GROUP concludes that the Western European prevalence of PAD and CLI has grown substantially over the last 7 years. This increase primarily reflects the significantly higher prevalence of diabetes.
“Because of the epidemic of diabetes, and the fact that diabetics represent 60% to 80% of CLI patients, critical limb ischemia has grown rapidly in Western Europe. Since CLI is very costly to treat, this has serious implications for healthcare expenditures, as well as for patient morbidity and mortality,” declared Mary L. Yost, President of THE SAGE GROUP.
The largest number of citizens suffering from PAD and CLI are located in Germany, Italy, Spain, the UK and France. These 5 countries account for 75% of PAD and 78% of CLI in Western Europe.
“With 940,000 citizens suffering from critical limb ischemia, Germany represents the single largest Western European market,” stated Ms. Yost. “This reflects the fact that Germany has the greatest number of elderly citizens, plus the second highest regional prevalence of diabetes,” Yost explained.
“Germany is followed closely in market size by Italy with over 766,000 people estimated to suffer from severe ischemia,” continued Ms. Yost.
Comparing the size of the Western Europe market with the U.S., Yost stated, “At 28 million, the Western European prevalence of PAD is considerably higher than the 20 million in the U.S. This reflects the greater number of middle-aged and elderly citizens. The number with CLI also exceeds that in the U.S., or 4.2 million versus 3.4 million.”
About the Report: Western Europe Prevalence and Incidence of Peripheral Artery Disease and Critical Limb ischemia
The report contains a comprehensive analysis of the current prevalence of diabetes, PAD and CLI in each of the 15 major markets of Western Europe and projects these numbers for the 2015-2030 period. PAD and CLI incidence estimates are also included.
Additional information: http://thesagegroup.us/pages/reports/w-europe-pad-cli.php.
THE SAGE GROUP, a research and consulting company, specializes in peripheral vascular disease in the lower limbs, specifically chronic venous disease (CVD), PAD, CLI, intermittent claudication (IC), diabetic foot ulcers (DFU) and the costs and consequences of amputation. Additional information: www.thesagegroup.us.
SOURCE: THE SAGE GROUP
THE SAGE GROUP, Beaufort SC
Mary Yost, (404) 520-6652